Seeing Is Believing
BNTX is currently covered by 12 analysts with an average potential upside of $22.95 (12.98%) backed by displayed 71 price targets and 103 ratings.
Analysts average stock forecasts to be materialized ratio is 55.86% with an average time for these price targets to be met of 52.14 days.
Highest price target for BNTX is 358, Lowest price target is 104, average price target is 231.
Most recent stock forecast was given by ROBERT BURNS from HCWAINWRIGHT on 28-Aug-2023. First documented stock forecast 05-Nov-2019.
Currently, out of the existing stock ratings of BNTX - 36 which are a Hold (64.29%), 19 which are a Buy (33.93%), 1 which are a Sell (1.79%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
180
$76.88 (74.55%)
180
1 months ago
3/17 (17.65%)
$84.32 (58.19%)
21
Hold
170
$66.88 (64.86%)
4 months 11 days ago
0/1 (0%)
$64.85 (61.67%)
Hold
128
$24.88 (24.13%)
142
5 months 18 days ago
3/4 (75%)
$-14.91 (-16.26%)
45
Hold
153
$49.88 (48.37%)
170
5 months 28 days ago
3/4 (75%)
$-14.68 (2.06%)
17
Hold
150
$46.88 (45.46%)
150
5 months 29 days ago
0/10 (0%)
$45.84 (29.97%)
What is BNTX (BioNTech SE Sponsored ADR) average time for price targets to be met?
Which analyst has the current highest performing score on BNTX (BioNTech SE Sponsored ADR) with a proven track record?
Which analyst has the most public recommendations on BNTX (BioNTech SE Sponsored ADR)?
Which analyst is the currently most bullish on BNTX (BioNTech SE Sponsored ADR)?
Which analyst is the currently most reserved on BNTX (BioNTech SE Sponsored ADR)?